106 related articles for article (PubMed ID: 16091732)
21. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
[TBL] [Abstract][Full Text] [Related]
22. Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts.
Shahrzad S; Shirasawa S; Sasazuki T; Rak JW; Coomber BL
Oncogene; 2008 Jun; 27(26):3729-38. PubMed ID: 18223682
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M
Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.
Saud SM; Li W; Morris NL; Matter MS; Colburn NH; Kim YS; Young MR
Carcinogenesis; 2014 Dec; 35(12):2778-86. PubMed ID: 25280562
[TBL] [Abstract][Full Text] [Related]
27. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
Camaj P; Primo S; Wang Y; Heinemann V; Zhao Y; Laubender RP; Stintzing S; Giessen-Jung C; Jung A; Gamba S; Bruns CJ; Modest DP
Future Oncol; 2015; 11(13):1919-29. PubMed ID: 26161928
[TBL] [Abstract][Full Text] [Related]
28. Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells.
Trinidad AG; Whalley N; Rowlinson R; Delpuech O; Dudley P; Rooney C; Critchlow SE
Oncogene; 2017 Nov; 36(44):6164-6176. PubMed ID: 28692044
[TBL] [Abstract][Full Text] [Related]
29. KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
Najumudeen AK; Fey SK; Millett LM; Ford CA; Gilroy K; Gunduz N; Ridgway RA; Anderson E; Strathdee D; Clark W; Nixon C; Morton JP; Campbell AD; Sansom OJ
Nat Commun; 2024 Jan; 15(1):100. PubMed ID: 38168062
[TBL] [Abstract][Full Text] [Related]
30. BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer.
Bartolini A; Cardaci S; Lamba S; Oddo D; Marchiò C; Cassoni P; Amoreo CA; Corti G; Testori A; Bussolino F; Pasqualini R; Arap W; Corà D; Di Nicolantonio F; Marchiò S
Clin Cancer Res; 2016 Oct; 22(19):4923-4933. PubMed ID: 27143691
[TBL] [Abstract][Full Text] [Related]
31. [Blood oncogene detection in patients with colorectal carcinoma].
Raedle J; Brieger A; Zeuzem S
Z Gastroenterol; 1998 Mar; 36(3):257-9. PubMed ID: 9577911
[No Abstract] [Full Text] [Related]
32. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
Terado T; Kim CJ; Ushio A; Minami K; Tambe Y; Kageyama S; Kawauchi A; Tsunoda T; Shirasawa S; Tanaka H; Inoue H
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894141
[TBL] [Abstract][Full Text] [Related]
33. KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer.
Cabot D; Brun S; Paco N; Ginesta MM; Gendrau-Sanclemente N; Abuasaker B; Ruiz-Fariña T; Barceló C; Cuatrecasas M; Bosch M; Rentero C; Pons G; Estanyol JM; Capellà G; Jaumot M; Agell N
Oncogene; 2021 Sep; 40(38):5730-5740. PubMed ID: 34333552
[TBL] [Abstract][Full Text] [Related]
34. Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression.
Shang A; Gu C; Zhou C; Yang Y; Chen C; Zeng B; Wu J; Lu W; Wang W; Sun Z; Li D
Cell Commun Signal; 2020 Mar; 18(1):52. PubMed ID: 32228650
[TBL] [Abstract][Full Text] [Related]
35. [Molecular tumor genesis of colorectal carcinoma].
Hilgers W; Schmiegel W
Praxis (Bern 1994); 1997 Sep; 86(39):1501-3. PubMed ID: 9411669
[No Abstract] [Full Text] [Related]
36. Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.
Smakman N; van den Wollenberg DJ; Borel Rinkes IH; Hoeben RC; Kranenburg O
J Virol; 2005 Dec; 79(23):14981-5. PubMed ID: 16282499
[TBL] [Abstract][Full Text] [Related]
37. Environment-gene interactions in intestinal cancer.
Augenlicht LH; Heerdt BG; Mariadason JM; Yang W; Wilson AJ; Fragale A; Velcich A
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S12-7. PubMed ID: 12570330
[TBL] [Abstract][Full Text] [Related]
38. Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9.
Yu B; Swatkoski S; Holly A; Lee LC; Giroux V; Lee CS; Hsu D; Smith JL; Yuen G; Yue J; Ann DK; Simpson RM; Creighton CJ; Figg WD; Gucek M; Luo J
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1724-33. PubMed ID: 25805818
[TBL] [Abstract][Full Text] [Related]
39. Combination Therapy with KRAS and P38α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line.
Kamran S; Seyedrezazadeh E; Shanehbandi D; Asadi M; Zafari V; Shekari N; Namvar L; Zarredar H
J Gastrointest Cancer; 2022 Sep; 53(3):597-604. PubMed ID: 34292499
[TBL] [Abstract][Full Text] [Related]
40. Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer.
Liu H; Liang Z; Cheng S; Huang L; Li W; Zhou C; Zheng X; Li S; Zeng Z; Kang L
Adv Sci (Weinh); 2023 Feb; 10(6):e2203757. PubMed ID: 36599679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
